✦ LIBER ✦

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

✍ Scribed by Robert L. Coleman; Michael W. Sill; Heather A. Lankes; Amanda Nickles Fader; Neil J. Finkler; James S. Hoffman; Peter G. Rose; Gregory P. Sutton; Charles W. Drescher; D. Scott McMeekin; Wei Hu; Michael Deavers; Andrew K. Godwin; R. Katherine Alpaugh; Anil K. Sood

Book ID: 118506841
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 246 KB
Volume: 127
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.08.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of danazol in advanced, r

Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study

✍ Allan Covens; Virginia L Brunetto; Maurie Markman; James W Orr Jr.; Samuel S Len 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Dactinomycin in the Treatment of Recurre

Dactinomycin in the Treatment of Recurrent or Persistent Endometrial Carcinoma: A Phase II Study of the Gynecologic Oncology Group

✍ David H. Moore; John A. Blessing; Charles Dunton; Richard E. Buller; Gary C. Rei 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 33 KB

A phase II evaluation of weekly docetaxe

A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: A study by the Gynecologic Oncology Group

✍ Agustin A. Garcia; John A. Blessing; Susan Nolte; Robert S. Mannel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Evaluation of irofulven (MGI-114) in the

Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group

✍ Russell J. Schilder; John A. Blessing; Michael L. Pearl; Peter G. Rose 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 67 KB

A Phase II Trial of Anastrozole in Advan

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

✍ Peter G. Rose; Virginia L. Brunetto; Linda VanLe; Jeffrey Bell; Joan L. Walker; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A phase II study of gemcitabine (gemzar,

A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study

✍ David L. Tait; John A. Blessing; James S. Hoffman; Kathleen N. Moore; Nick M. Sp 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 151 KB